Michael Thirman to Patient Safety
This is a "connection" page, showing publications Michael Thirman has written about Patient Safety.
Connection Strength
0.113
-
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study. Lancet Oncol. 2018 02; 19(2):216-228.
Score: 0.113